Cited by 498Cytokine Signaling Pathways and InteractionsNeuroinflammation and Neurodegeneration MechanismsTryptophan and brain disorders

The DOI matches its Crossref record; 167 of the 170 references it cites were found in a registry or an index.

The role of interleukin-6 signaling in nervous tissue

Open access

Rothaug, Michelle, Becker-Pauly, Christoph, Rose-John, Stefan·2016·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

DOI 10.1016/j.bbamcr.2016.03.018

Open this paper in CoChat — free account Open PDF

Abstract

The cytokine interleukin-6 (IL-6) plays a critical role in the pathogenesis of inflammatory disorders and in the physiological homeostasis of neural tissue. Profound neuropathological changes, such as multiple sclerosis (MS), Parkinson's and Alzheimer's disease are associated with increased IL-6 expression in brain. Increased nocturnal concentrations of serum IL-6 are found in patients with impaired sleep whereas IL-6-deficient mice spend more time in rapid eye movement sleep associated with dreaming. IL-6 is crucial in the differentiation of oligodendrocytes, regeneration of peripheral nerves and acts as a neurotrophic factor. It exerts its cellular effects through two distinct pathways which include the anti-inflammatory pathway involving the membrane-bound IL-6 receptor (IL-6R) expressed on selective cells, including microglia, in a process known as classical signaling that is also critical for bacterial defense. In classical signaling binding of IL-6 to the membrane-bound IL-6R activates the β-receptor glycoprotein 130 (gp130) and subsequent down-stream signaling. The alternative, rather pro-inflammatory pathway, shown to mediate neurodegeneration in mice, termed trans-signaling, depends on a soluble form of the IL-6R that is capable of binding IL-6 to stimulate a response on distal cells that express gp130. A naturally occurring soluble form of gp130 (sgp130) has been identified that can specifically bind and neutralize the IL-6R/IL-6 complex. Thus, trans-signaling is blocked but classical signaling is completely unaffected. A modified, recombinant dimerized version of sgp130 (sgp130Fc) has successfully been used to block inflammatory processes in mice and may also be used in the clarification of IL-6 trans-signaling in neurological diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.bbamcr.2016.03.018

Cites

167 of 167 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272 · cited 1×
“inhibitory factor (LIF), oncostatin M (OSM), cardiotrophin-1 (CT-1), neuropoietin and cardiotrophin-like cytokine factor-1 (also known as new neurotrophin 1 and B cell stimulatory factor-3) [24-28].”
Background
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
Pedersen, B. K., & Febbraio, M. A. (2008) · Physiological Reviews · doi:10.1152/physrev.90100.2007 · Cited by 2,388
IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jäger, A., Strom, T. B., Oukka, M., & Kuchroo, V. K. (2007) · Nature · doi:10.1038/nature05970 · Cited by 1,896
Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.
Gauldie, J., Richards, C. D., Harnish, D. C., Lansdorp, P. M., & Baumann, H. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,538
Control of sleep and wakefulness
Brown, R. E., Basheer, R., McKenna, J. T., Strecker, R. E., & McCarley, R. W. (2012) · Physiological Reviews · doi:10.1152/physrev.00032.2011 · Cited by 1,477
gp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,468
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396
Interleukin-6 family of cytokines and gp130.
Kishimoto, T., Akira, S., Narazaki, M., & Taga, T. (1995) · Blood · doi:10.1182/blood.v86.4.1243.bloodjournal8641243 · Cited by 1,362
Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF)
Akira, S., Hirano, T., Taga, T., & Kishimoto, T. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.11.2199284 · Cited by 1,306
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Relationship between Adipocyte Size and Adipokine Expression and Secretion
Skurk, T., Alberti-Huber, C., Herder, C., & Hauner, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1055 · Cited by 1,288
Sleep and immune function
Besedovsky, L., Lange, T., & Born, J. (2012) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-011-1044-0 · Cited by 1,153
Structural conversion of neurotoxic amyloid-β1–42 oligomers to fibrils
Ahmed, M., Davis, J., Aucoin, D., Sato, T., Ahuja, S., Aimoto, S., Elliott, J. I., Van Nostrand, W. E., & Smith, S. O. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1799 · Cited by 1,111
Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway.
Bonni, A., Sun, Y., Nadal-Vicens, M., Bhatt, A. S., Frank, D., Rozovsky, I., Stahl, N., Yancopouloš, G., & Greenberg, M. (1997) · Science · doi:10.1126/science.278.5337.477 · Cited by 1,050
Molecular cloning and expression of an IL-6 signal transducer, gp130
Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., & Kishimoto, T. (1990) · Cell · doi:10.1016/0092-8674(90)90411-7 · Cited by 1,039
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1
Wu, C., Yosef, N., Thalhamer, T., Zhu, C., Xiao, S., Kishi, Y., Regev, A., & Kuchroo, V. K. (2013) · Nature · doi:10.1038/nature11984 · Cited by 1,022
THE CELL BIOLOGY OF THE BLOOD-BRAIN BARRIER
Rubin, L. L., & Staddon, J. M. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.11 · Cited by 1,017
Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.
Campbell, I. L., Abraham, C. R., Masliah, E., Kemper, P., Inglis, J. D., Oldstone, M. B., & Mucke, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10061 · Cited by 1,006
The genetic landscape of Alzheimer disease: clinical implications and perspectives
Van Cauwenberghe, C., Van Broeckhoven, C., & Sleegers, K. (2016) · Genetics in Medicine · doi:10.1038/gim.2015.117 · Cited by 863
A review of Parkinson's disease
Davie, C. A. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn013 · Cited by 858
Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients
Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90508-8 · Cited by 855
A circadian clock in macrophages controls inflammatory immune responses
Keller, M., Mazuch, J., Abraham, U., Eom, G. D., Herzog, E. D., Volk, H.-D., Kramer, A., & Maier, B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906361106 · Cited by 843 · cited 1×
“Additionally, the sheddase of the IL-6R, ADAM17 is expressed in a sleep-dependent manner, at least in macrophages [139].”
Background
Restoration of brain energy metabolism as the function of sleep
Benington, J. H., & Heller, H. C. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(94)00057-o · Cited by 828
Soluble receptors for cytokines and growth factors: generation and biological function
Rose‐John, S., & Heinrich, P. C. (1994) · Biochemical Journal · doi:10.1042/bj3000281 · Cited by 777
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis
De Benedetti, F., Brunner, H. I., Ruperto, N., Kenwright, A., Wright, S., Calvo, I., Cuttica, R., Ravelli, A., Schneider, R., Woo, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112802 · Cited by 763
Oxidative damage in multiple sclerosis lesions
Haider, L., Fischer, M. T., Frischer, J., Bauer, J., Höftberger, R., Botond, G., Esterbauer, H., Binder, C., Witztum, J., & Lassmann, H. (2011) · Brain : a journal of neurology · doi:10.1093/brain/awr128 · Cited by 754
Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases
Chin-Chan, M., Navarro-Yepes, J., & Quintanilla‐Vega, B. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00124 · Cited by 746
TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.020 · Cited by 726
How (and why) the immune system makes us sleep
Imeri, L., & Opp, M. R. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2576 · Cited by 710
Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2).
Hirano, T., Taga, T., Nakano, N., Yasukawa, K., Kashiwamura, S., Shimizu, K., Nakajima, K., Pyun, K., & Kishimoto, T. (1985) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.82.16.5490 · Cited by 691
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Jones, S. A., Scheller, J., & Rose‐John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 689
Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M., & Rose-John, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01867.x · Cited by 665
Inflammasomes in the CNS
Walsh, J. G., Muruve, D. A., & Power, C. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3638 · Cited by 637 · cited 1×
“Some cytokines play a role in signaling within the central nervous system (CNS) in the regulation of sleep, the generation and recall of long-term memory, the focus of attention as well as in neurodegenerative diseases and the integrity of the blood–brain-barrier [1,2].”
Background
Haemopoietic receptors and helical cytokines
Bazán, J. F. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90139-z · Cited by 633
Interleukin 6 is required for the development of collagen-induced arthritis
Alonzi, T., Fattori, E., Lazzaro, D., Costa, P., Probert, L., Kollias, G., De Benedetti, F., Poli, V., & Ciliberto, G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.461 · Cited by 604
Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction
Ogura, H., Murakami, M., Okuyama, Y., Tsuruoka, M., Kitabayashi, C., Kanamoto, M., Nishihara, M., Iwakura, Y., & Hirano, T. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.018 · Cited by 564
A bioactive designer cytokine for human hematopoietic progenitor cell expansion
Fischer, M., Goldschmitt, J., Peschel, C., Brakenhoff, J., Kallen, K., Wollmer, A., Grötzinger, J., & Rose-John, S. (1997) · Nature Biotechnology · doi:10.1038/nbt0297-142 · Cited by 551
Interleukin-6: Biology, signaling and strategies of blockade
Schaper, F., & Rose‐John, S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.004 · Cited by 532
Defective inflammatory response in interleukin 6-deficient mice.
Fattori, E., Cappelletti, M., Costa, P., Sellitto, C., Cantoni, L., Carelli, M., Faggioni, R., Fantuzzi, G., Ghezzi, P., & Poli, V (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1243 · Cited by 525
The soluble interleukin‐6 receptor is generated by shedding
Müllberg, J., Schooltink, H., Stoyan, T., Günther, M., Graeve, L., Buse, G., Mackiewicz, A. A., Heinrich, P. C., & Rose‐John, S. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230226 · Cited by 515
Structure and expression of human B cell stimulatory factor‐2 (BSF‐2/IL‐6) gene.
Yasukawa, K., Hirano, T., Watanabe, Y., Muratani, K., Matsuda, T., Nakai, S., & Kishimoto, T. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02598.x · Cited by 503
Structure and expression of cDNA and genes for human interferon‐beta‐2, a distinct species inducible by growth‐stimulatory cytokines.
Zilberstein, A., Ruggieri, R., Korn, J. H., & Revel, M. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04531.x · Cited by 486
Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices
Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Yolk, B., & Berger, M. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80737-n · Cited by 483
IL-6-Deficient Mice Are Resistant to Experimental Autoimmune Encephalomyelitis: Roles of IL-6 in the Activation and Differentiation of Autoreactive T Cells
Samoilova, E. B., Horton, J. L., Hilliard, B. A., Liu, T.-S. T., & Chen, Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6480 · Cited by 441
Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130
Narazaki, M., Yasukawa, K., Saito, T., Ohsugi, Y., Fukui, H., Koishihara, Y., Yancopoulos, G. D., Taga, T., & Kishimoto, T. (1993) · Blood · doi:10.1182/blood.v82.4.1120.bloodjournal8241120 · Cited by 431
Redox regulation of glial inflammatory response to lipopolysaccharide and interferonγ
Pawate, S., Shen, Q., Fan, F., & Bhat, N. R. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20180 · Cited by 428
Structural Biology of Shared Cytokine Receptors
Wang, X., Lupardus, P. J., LaPorte, S. L., & García, K. C. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090616 · Cited by 417
Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia
Klein, B., Wijdenes, J., Zhang, X., Jourdan, M., Boiron, J.-M., Brochier, J., Liautard, J., Merlin, M., Clement, C., & Morel-Fournier, B. (1991) · Blood · doi:10.1182/blood.v78.5.1198.1198 · Cited by 417
The neuropoietic cytokine family in development, plasticity, disease and injury
Bauer, Š., Kerr, B. J., & Patterson, P. H. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2054 · Cited by 412
Physiological and pathological roles of interleukin-6 in the central nervous system
Gruol, D. L., & Nelson, T. E. (1997) · Molecular Neurobiology · doi:10.1007/bf02740665 · Cited by 409
Plasticity and cross-talk of Interleukin 6-type cytokines
Garbers, C., Hermanns, H. M., Schaper, F., Müller‐Newen, G., Grötzinger, J., Rose‐John, S., & Scheller, J. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.04.001 · Cited by 409
Cellular Cholesterol Depletion Triggers Shedding of the Human Interleukin-6 Receptor by ADAM10 and ADAM17 (TACE)
Matthews, V., Schuster, B., Schütze, S., Bussmeyer, I., Ludwig, A., Hundhausen, C., Sadowski, T., Saftig, P., Hartmann, D., Kallen, K.-J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210584200 · Cited by 390
Cytokine Actions in the Central Nervous System
Benveniste, E. N. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)00015-x · Cited by 383
Cytokines, chemokines, and cytokine receptors in human microglia
Lee, Y. B., Nagai, A., & Kim, S. U. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10253 · Cited by 363
Demyelinating diseases
Love, S. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.031195 · Cited by 363
Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants
Bien‐Ly, N., Yu, Y. J., Bumbaca, D., Elstrott, J., Boswell, C. A., Zhang, Y., Luk, W., Lu, Y., Dennis, M. S., Weimer, R. M., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131660 · Cited by 356
IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis
Serada, S., Fujimoto, M., Mihara, M., Koike, N., Ohsugi, Y., Nomura, S., Yoshida, H., Nishikawa, T., Terabe, F., Ohkawara, T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802218105 · Cited by 351
Sympathetic neurons can produce and respond to interleukin 6.
März, P., Cheng, J. G., Gadient, R., Patterson, P. H., Stoyan, T., Otten, U., & Rose-John, S. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.6.3251 · Cited by 346
Accelerated Nerve Regeneration in Mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma
Hirota, H., Kiyama, H., Kishimoto, T., & Taga, T. (1996) · Journal of Experimental Medicine · doi:10.1084/jem.183.6.2627 · Cited by 338
Structural analysis of the sequence coding for an inducible 26‐kDa protein in human fibroblasts
Haegeman, G., Content, J., Volckaert, G., DERYNCK, R., Tavernier, J. H., & Fiers, W. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09931.x · Cited by 336
Role of cytokines in inflammatory process in Parkinson’s disease
Sawada, M., Imamura, K., & Nagatsu, T. (2006) · Parkinson’s Disease and Related Disorders · doi:10.1007/978-3-211-45295-0_57 · Cited by 331
Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime
Vgontzas, A. N., Zoumakis, M., Papanicolaou, D. A., Bixler, E. O., Prolo, P., Lin, H.-M., Vela-Bueno, A., Kales, A., & Chrousos, G. P. (2002) · Metabolism · doi:10.1053/meta.2002.33357 · Cited by 329
IL-6 biology: implications for clinical targeting in rheumatic disease
Calabrese, L., & Rose-John, S. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.127 · Cited by 329
Massive gliosis induced by interleukin‐6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition
Chakrabarty, P., Jansen‐West, K., Beccard, A., Ceballos‐Diaz, C., Levites, Y., Verbeeck, C., Zubair, A. C., Dickson, D., Golde, T. E., & Das, P. (2010) · The FASEB Journal · doi:10.1096/fj.09-141754 · Cited by 328
Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor
Lust, J. A., Donovan, K. A., Kline, M. P., Greipp, P. R., Kyle, R. A., & Maihle, N. J. (1992) · Cytokine · doi:10.1016/1043-4666(92)90043-q · Cited by 316
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial
Brunner, H. I., Ruperto, N., Żuber, Z. M., Keane, C., Harari, O., Kenwright, A., Lü, P., Cuttica, R. J., Keltsev, V., Xavier, R. M., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205351 · Cited by 313
Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures
Hama, T., Kushima, Y., Miyamoto, M., Kubota, M., Takei, N., & Hatanaka, H. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90132-8 · Cited by 301
Aggregated α-Synuclein Mediates Dopaminergic Neurotoxicity In Vivo
Periquet, M., Fulga, T. A., Myllykangas, L., Schlossmacher, M. G., & Feany, M. Β. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0285-07.2007 · Cited by 299
Impaired neuroglial activation in interleukin‐6 deficient mice
Klein, M., Möller, J., Jones, L., Bluethmann, H., Kreutzberg, G., & Raivich, G. (1997) · Glia · doi:10.1002/(sici)1098-1136(199703)19:3 · Cited by 298
Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia
Sondag, C. M., Dhawan, G., & Combs, C. K. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-1 · Cited by 295
Plasma clearance, organ distribution and target cells of interleukin‐6/hepatocyte‐stimulating factor in the rat
Castell, J. V., Geiger, T. M., Groß, V., Andus, T., WALTER, E., Hirano, T., Kishimoto, T., & Heinrich, P. C. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14383.x · Cited by 290
Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo
Saito, M., Yoshida, K., Hibi, M., Taga, T., & Kishimoto, T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.12.4066 · Cited by 282
Soluble IL-6 Receptor Governs IL-6 Activity in Experimental Arthritis: Blockade of Arthritis Severity by Soluble Glycoprotein 130
Nowell, M. A., Richards, P. J., Horiuchi, S., Yamamoto, N., Rose‐John, S., Topley, N., Williams, A. S., & Jones, S. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3202 · Cited by 269
Cytokine receptors and signal transduction
Taga, T., & Kishimoto, T. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.15.1334470 · Cited by 267
Transgenic blockade of interleukin 6 transsignaling abrogates inflammation.
Rabe, B., Chalaris, A., May, U., Waetzig, G. H., Seegert, D., Williams, A., Jones, S. A., Rose-John, S., & Scheller, J. (2008) · Blood · doi:10.1182/blood-2007-07-102137 · Cited by 254
A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor
Müllberg, J., Durie, F. H., Otten-Evans, C., Alderson, M. R., Rose‐John, S., Cosman, D. J., Black, R. A., & Mohler, K. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.11.5198 · Cited by 250
Interleukin-6 (IL-6) Production by Astrocytes: Autocrine Regulation by IL-6 and the Soluble IL-6 Receptor
Wagoner, N. J. V., Oh, J., Repovic, P., & Benveniste, E. N. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05236.1999 · Cited by 250
Trans-Signaling Is a Dominant Mechanism for the Pathogenic Actions of Interleukin-6 in the Brain
Campbell, I. L., Erta, M., Lim, S. L., Frausto, R. F., May, U., Rose‐John, S., Scheller, J., & Hidalgo, J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2830-13.2014 · Cited by 247
MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis
Murugaiyan, G., da Cunha, A. P., Ajay, A. K., Joller, N., Garo, L. P., Kumaradevan, S., Yosef, N., Vaidya, V. S., & Weiner, H. L. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74347 · Cited by 245
Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein
Wood, J. A., Wood, P. L., Ryan, R., Graff-Radford, N. R., Pilapil, C., Robitaille, Y., & Quirion, R. (1993) · Brain Research · doi:10.1016/0006-8993(93)91327-o · Cited by 244
IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein.
Okuda, Y., Sakoda, S., Bernard, C. C. A., Fujimura, H., Saeki, Y., Kishimoto, T., & Yanagihara, T. (1998) · International Immunology · doi:10.1093/intimm/10.5.703 · Cited by 244
Impaired Nighttime Sleep in Healthy OldVersusYoung Adults Is Associated with Elevated Plasma Interleukin-6 and Cortisol Levels: Physiologic and Therapeutic Implications
Vgontzas, A. N., Zoumakis, M., Bixler, E. O., Lin, H.-M., Prolo, P., Vela‐Bueno, A., Kales, A., & Chrousos, G. P. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021176 · Cited by 243
Cutting Edge: Trans- Signaling via the Soluble IL-6R Abrogates the Induction of FoxP3 in Naive CD4+CD25− T Cells
Dominitzki, S., Fantini, M. C., Neufert, C. F., Nikolaev, A., Galle, P. R., Scheller, J., Monteleone, G., Rose‐John, S., Neurath, M. F., & Becker, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2041 · Cited by 228
Genes coding for RNA polymerase β subunit in bacteria
Lisitsyn, N. A., MONASTYRSKAYA, G. S., & Sverdlov, E. D. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14384.x · Cited by 217
Humanization of anti‐human insulin receptor antibody for drug targeting across the human blood–brain barrier
Boado, R. J., Zhang, Y., Zhang, Y., & Pardridge, W. M. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21120 · Cited by 213
Essential Roles of IL-6 Trans -Signaling in Colonic Epithelial Cells, Induced by the IL-6/Soluble–IL-6 Receptor Derived from Lamina Propria Macrophages, on the Development of Colitis-Associated Premalignant Cancer in a Murine Model
Matsumoto, S., Hara, T., Mitsuyama, K., Yamamoto, M., Tsuruta, O., Sata, M., Scheller, J., Rose‐John, S., Kado, S., & Takada, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801217 · Cited by 211
Sleep after Vaccination Boosts Immunological Memory
Lange, T., Dimitrov, S., Bollinger, T., Diekelmann, S., & Born, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100015 · Cited by 201
Reengineering Biopharmaceuticals for Targeted Delivery Across the Blood–Brain Barrier
Pardridge, W. M., & Boado, R. J. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-396962-0.00011-2 · Cited by 199
Increased nocturnal interleukin-6 excretion in patients with primary insomnia: A pilot study
Burgos, I., Richter, L., Klein, T., Fiebich, B., Feige, B., Lieb, K., Voderholzer, U., & Riemann, D. (2006) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.06.007 · Cited by 198
Soluble interleukin‐6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism
Horiuchi, S., Koyanagiu, Y., Zhouu, Y., Miyamoto, H., Tanakau, Y., Waki, M., Matsumoto, A., Yamamotou, M., & Yamamoto, N. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240837 · Cited by 197
Short communication Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease
Müller, T., Blum-Degen, D., Przuntek, H., & Kuhn, W. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1998.tb01736.x · Cited by 195
Humanized Antihuman IL-6 Receptor Antibody, Tocilizumab
Nishimoto, N., & Kishimoto, T. (2007) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-73259-4_7 · Cited by 185
Ischemia-Induced Interleukin-6 as a Potential Endogenous Neuroprotective Cytokine against NMDA Receptor-Mediated Excitoxicity in the Brain
Ali, C., Nicole, O., Docagne, F., Lesné, S., MacKenzie, E. T., Nouvelot, A., Buisson, A., & Vivien, D. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200006000-00008 · Cited by 185
Role of interleukin‐6 and soluble IL‐6 receptor in region‐specific induction of astrocytic differentiation and neurotrophin expression
März, P., Heese, K., Dimitriades‐Schmutz, B., Rose‐John, S., & Otten, U. (1999) · Glia · doi:10.1002/(sici)1098-1136(199905)26:3 · Cited by 177
Extramedullary Expansion of Hematopoietic Progenitor Cells in Interleukin (IL)-6–sIL-6R Double Transgenic Mice
Peters, M., Schirmacher, P., Goldschmitt, J., Odenthal, M., Peschel, C., Fattori, E., Ciliberto, G., Dienes, H., Buschenfelde, K. Z. Z., & Rose-John, S. (1997) · Journal of Experimental Medicine · doi:10.1084/jem.185.4.755 · Cited by 176
Cutting Edge: Soluble IL-6R Is Produced by IL-6R Ectodomain Shedding in Activated CD4 T Cells
Briso, E. M., Dienz, O., & Rincón, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7102 · Cited by 165
IL-6 detection in multiple sclerosis brain
Maimone, D., Guazzi, G. C., & Annunziata, P. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)00283-3 · Cited by 164
Shedding of interleukin‐6 receptor and tumor necrosis factor α
Althoff, K., Reddy, P., Voltz, N., Rose‐John, S., & Müllberg, J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01278.x · Cited by 162
IL‐6 Expression in Neurons of Transgenic Mice Causes Reactive Astrocytosis and Increase in Ramified Microglial Cells but no Neuronal Damage
Fattori, E., Lazzaro, D., Musiani, P., Modesti, A., Alonzi, T., & Ciliberto, G. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01042.x · Cited by 162
IL-17 Enhancement of the IL-6 Signaling Cascade in Astrocytes
Ma, X., Reynolds, S. L., Baker, B. J., Li, X., Benveniste, E. N., & Qin, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000142 · Cited by 161
Expression of cytokine receptors in cultured neuronal and glial cells
Sawada, M., Itoh, Y., Suzumura, A., & Marunouchi, T. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90396-3 · Cited by 160
IL-6 Controls the Innate Immune Response against Listeria monocytogenes via Classical IL-6 Signaling
Hoge, J., Yan, I., Jänner, N., Schumacher, V., Chalaris, A., Steinmetz, O. M., Engel, D. R., Scheller, J., Rose‐John, S., & Mittrücker, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201044 · Cited by 158
Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons
Toulmond, S., Vigé, X., Fage, D., & Bénavidès, J. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90713-h · Cited by 155
Axonal Damage in Multiple Sclerosis
Haines, J. D., Inglese, M., & Casaccia, P. (2011) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20246 · Cited by 151
Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood–brain barrier delivery in the mouse
Boado, R. J., Zhang, Y., Wang, Y., & Pardridge, W. M. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.22135 · Cited by 146
Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex.
Ringheim, G., Szczepanik, A. M., Petko, W., Burgher, K. L., Zhu, S. Z., & Chao, C. (1998) · Brain Research. Molecular Brain Research · doi:10.1016/s0169-328x(97)00356-2 · Cited by 140
Interleukin-6 is elevated in plasma in multiple sclerosis
Krei, K., Fredrikson, S., Fontana, A., & Link, H. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90020-8 · Cited by 130
Liver regeneration induced by a designer human IL‐6/ sIL‐6R fusion protein reverses severe hepatocellular injury
Galun, E., Zeira, E., Pappo, O., Peters, M., & Rose-John, S. (2000) · The FASEB Journal · doi:10.1096/fj.99-0913com · Cited by 124
Self-citation
Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation
May, L. T., Torcia, M. G., Cozzolino, F., Ray, A., Tatter, S. B., Santhanam, U., Sehgal, P. B., & Stern, D. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92206-7 · Cited by 124
Secretory proteins induced in human fibroblasts under conditions used for the production of interferon beta.
Content, J., Wit, L. D., Piérard, D., Derynck, R., Clercq, E. D., & Fiers, W. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.9.2768 · Cited by 123
Site-Specific Production of IL-6 in the Central Nervous System Retargets and Enhances the Inflammatory Response in Experimental Autoimmune Encephalomyelitis
Quintana, A., Müller, M., Frausto, R. F., Ramos, R., Getts, D. R., Sanz, E., Hofer, M. J., Krauthausen, M., King, N. J. C., Hidalgo, J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900242 · Cited by 121
Interleukin-6 as a neurotrophic factor for promoting the survival of cultured catecholaminergic neurons in a chemically defined medium from fetal and postnatal rat midbrains
Kushima, Y., Hama, T., & Hatanaka, H. (1992) · Neuroscience Research · doi:10.1016/0168-0102(92)90039-f · Cited by 120
STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice
Mitsuyama, K., Matsumoto, S., Rose‐John, S., Suzuki, A., Hara, T., Tomiyasu, N., Handa, K., Tsuruta, O., Funabashi, H., Scheller, J., et al. (2006) · Gut · doi:10.1136/gut.2005.079343 · Cited by 120
Sleep enhances IL‐6 trans‐signaling in humans
Dimitrov, S., Lange, T., Benedict, C., Nowell, M. A., Jones, S. A., Scheller, J., Rose‐John, S., Born, J., Dimitrov, S., Lange, T., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-5754fje · Cited by 115
Self-citation
Interleukin-6 alters sleep of rats
Hogan, D. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00038-9 · Cited by 112
IL-6 promotes regeneration and functional recovery after cortical spinal tract injury by reactivating intrinsic growth program of neurons and enhancing synapse formation
Yang, P., Wen, H., Ou, S., Cui, J. G., & Fan, D. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.03.019 · Cited by 110
Interleukin-1β Enhances Survival and Interleukin-6 Protects against MPP+ Neurotoxicity in Cultures of Fetal Rat Dopaminergic Neurons
Akaneya, Y., Takahashi, M., & Hatanaka, H. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1082 · Cited by 110
Signaling mechanisms through cytokine receptors that share signal transducing receptor components
Taga, T., & Kishimoto, T. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80024-7 · Cited by 107
The stress-induced cytokine interleukin-6 decreases the inhibition/excitation ratio in the rat temporal cortex via trans-signaling
Garcia-Oscos, F., Salgado, H., Hall, S., Thomas, F., Farmer, G. E., Bermeo, J., Galindo, L. C., Ramirez, R. D., D'Mello, S., Rose-John, S., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.11.018 · Cited by 105
Microglia‐induced IL‐6 protects against neuronal loss following HSV‐1 infection of neural progenitor cells
Chucair‐Elliott, A. J., Conrady, C. D., Zheng, M., Menendez, C. M., Lane, T. E., & Carr, D. J. J. (2014) · Glia · doi:10.1002/glia.22689 · Cited by 104
High amounts of circulating interleukin (IL)‐6 in the form of monomeric immune complexes during anti‐IL‐6 therapy. Towards a new methodology for measuring overall cytokine production in human in vivo
Lu, Z., Brochier, J., Wijdenes, J., Brailly, H., Bataille, R., & Klein, B. (1992) · European Journal of Immunology · doi:10.1002/eji.1830221110 · Cited by 102
Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25− and CD25high regulatory T cells
Oberg, H., Wesch, D., Grüssel, S., Rose‐John, S., & Kabelitz, D. (2006) · International Immunology · doi:10.1093/intimm/dxh396 · Cited by 102
Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis
Richards, P. J., Nowell, M. A., Horiuchi, S., McLoughlin, R. M., Fielding, C. A., Grau, S., Yamamoto, N., Ehrmann, M., Rose‐John, S., Williams, A. S., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21818 · Cited by 99
Increased vulnerability of dopaminergic neurons in MPTP‐lesioned interleukin‐6 deficient mice
Bolin, L., Strycharska-Orczyk, I., Murray, R., Langston, J., & Monte, D. D. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01131.x · Cited by 95
The effects of hepatocyte stimulating factor on fibrinogen biosynthesis in hepatocyte monolayers.
Fuller, G. M., Otto, J. M., Woloski, B. M. R. N. J., McGary, C. T., & Adams, M. A. (1985) · The Journal of Cell Biology · doi:10.1083/jcb.101.4.1481 · Cited by 93
Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice
Naito, Y., Takagi, T., Uchiyama, K., Kuroda, M., Kokura, S., Ichikawa, H., Yanagisawa, R., Inoue, K.-I., Takano, H., Satoh, M., et al. (2004) · International Journal of Molecular Medicine · doi:10.3892/ijmm.14.2.191 · Cited by 92
Enhancing influence of intranasal interleukin‐6 on slowwave activity and memory consolidation during sleep
Benedict, C., Scheller, J., Rose‐John, S., Jan Born, A., & Marshall, L. (2009) · The FASEB Journal · doi:10.1096/fj.08-122853 · Cited by 88
Sleep–wake behavior and responses of interleukin-6-deficient mice to sleep deprivation
Morrow, J. D., & Opp, M. R. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.02.003 · Cited by 85
β-AMYLOID FRAGMENT POTENTIATES IL-6 AND TNF-α SECRETION BY LPS IN ASTROCYTES BUT NOT IN MICROGLIA
Forloni, G., Mangiarotti, F., Angeretti, N., Lucca, E., & Simoni, M. G. D. (1997) · Cytokine · doi:10.1006/cyto.1997.0232 · Cited by 84
Interleukin-6 and leukemia inhibitory factor promote the survival of acetylcholinesterase-positive neurons in culture from embryonic rat spinal cord
Kushima, Y., & Hatanaka, H. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90244-2 · Cited by 81
Human slow wave sleep: A review and appraisal of recent findings, with implications for sleep functions, and psychiatric illness
Horne, J. A. (1992) · Cellular and Molecular Life Sciences · doi:10.1007/bf01919141 · Cited by 79
Interleukin-6, β-amyloid peptide and NMDA interactions in rat cortical neurons
Qiu, Z., & Gruol, D. L. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00158-9 · Cited by 79
Occurrence of Interleukin‐6 in Cortical Plaques of Alzheimer's Disease Patients May Precede Transformation of Diffuse into Neuritic Plaquesa
Hüll, M., Berger, T., Volk, B., & Bauer, J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34420.x · Cited by 77
Pathogenic and Protective Functions of TNF in Neuroinflammation Are Defined by Its Expression in T Lymphocytes and Myeloid Cells
Kruglov, A., Lampropoulou, V., Fillatreau, S., & Nedospasov, S. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100663 · Cited by 75
Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients
März, P., Heese, K., Höck, C., Golombowski, S., Müller-Spahn, F., Rose‐John, S., & Otten, U. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00886-0 · Cited by 74
Central inhibition of interleukin-6 trans-signaling during peripheral infection reduced neuroinflammation and sickness in aged mice
Burton, M. D., Rytych, J. L., Freund, G. G., & Johnson, R. W. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.01.002 · Cited by 73
IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier
Linker, R. A., Lühder, F., Kallen, K., Lee, D.-H., Engelhardt, B., Rose‐John, S., & Gold, R. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.007 · Cited by 73
Insulin Receptor Antibody–Sulfamidase Fusion Protein Penetrates the Primate Blood–Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type A Cells
Boado, R. J., Lu, J. Z., Hui, E. K., & Pardridge, W. M. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500258p · Cited by 71
Analysis of IL-6/gp130 family receptor expression reveals that in contrast to astroglia, microglia lack the oncostatin M receptor and functional responses to oncostatin M
Hsu, M.-P., Frausto, R. F., Rose‐John, S., & Campbell, I. L. (2014) · Glia · doi:10.1002/glia.22739 · Cited by 69
ABERRANT ACUTE-PHASE RESPONSE IN AGED INTERLEUKIN-6 KNOCKOUT MICE
Gomez, C., Góral, J., Ramirez, L., Kopf, M., & Kovacs, E. (2006) · Shock · doi:10.1097/01.shk.000029553.39081.ec · Cited by 63
Is IL-6 both a cytokine and a neurotrophic factor?
Wagner, J. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2417 · Cited by 63
Genetic requirement of p47 phox for superoxide production by murine microglia
Lavigne, M. C., Malech, H. L., Holland, S. M., & Leto, T. L. (2000) · The FASEB Journal · doi:10.1096/fj.00-0608fje · Cited by 59
The CREB/CRTC2 pathway modulates autoimmune disease by promoting Th17 differentiation
Hernandez, J. B., Chang, C., LeBlanc, M., Grimm, D., Le Lay, J., Kaestner, K. H., Zheng, Y., & Montminy, M. (2015) · Nature Communications · doi:10.1038/ncomms8216 · Cited by 53
Induction of IL‐6 release from human T cells by PAR‐1 and PAR‐2 agonists
Li, T., & He, S. (2006) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2006.01456.x · Cited by 50
IL-6 MODULATES SEPSIS-INDUCED DECREASES IN TRANSCRIPTION OF HEPATIC ORGANIC ANION AND BILE ACID TRANSPORTERS
Andrejko, K. M., Raj, N. R., Kim, P. K., Cereda, M. F., & Deutschman, C. S. (2008) · Shock · doi:10.1097/shk.0b013e318150762b · Cited by 48
Context‐dependent IL‐6 potentiation of interferon‐ gamma‐induced IL‐12 secretion and CD40 expression in murine microglia
Lin, H.-W., & Levison, S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06366.x · Cited by 48
Induction of atypical EAE mediated by transgenic production of IL‐6 in astrocytes in the absence of systemic IL‐6
Giralt, M., Ramos, R., Quintana, A., Ferrer, B., Erta, M., Castro-Freire, M., Comes, G., Sanz, E., Unzeta, M., Pifarré, P., et al. (2013) · Glia · doi:10.1002/glia.22457 · Cited by 46
Vagal nerve stimulation blocks interleukin 6-dependent synaptic hyperexcitability induced by lipopolysaccharide-induced acute stress in the rodent prefrontal cortex
Garcia-Oscos, F., Peña, D., Housini, M., Cheng, D., Lopez, D., Borland, M. S., Salgado-Delgado, R., Salgado, H., D’Mello, S., Kilgard, M. P., et al. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.07.020 · Cited by 43
Genetic Engineering, Expression, and Activity of a Chimeric Monoclonal Antibody−Avidin Fusion Protein for Receptor-Mediated Delivery of Biotinylated Drugs in Humans
Boado, R. J., Zhang, Y., Zhang, Y., Xia, C., Wang, Y., & Pardridge, W. M. (2008) · Bioconjugate Chemistry · doi:10.1021/bc7004076 · Cited by 41
Central β‐amyloid peptide‐induced peripheral interleukin‐6 responses in mice
Song, D., Im, Y., Jung, J., Cho, J., Suh, H., & Kim, Y. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00121.x · Cited by 40
Immunoinflammatory diseases of the central nervous system – the tale of two cytokines
Hofer, M. J., & Campbell, I. L. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13175 · Cited by 39
Delivery of a Peptide Radiopharmaceutical to Brain with an IgG-Avidin Fusion Protein
Zhou, Q.-H., Lu, J. Z., Hui, E. K., Boado, R. J., & Pardridge, W. M. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200174x · Cited by 33
Peripheral and central blockade of interleukin-6 trans-signaling differentially affects sleep architecture
Oyanedel, C. N., Kelemen, E., Scheller, J., Jan Born, A., & Rose‐John, S. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.07.001 · Cited by 30
Expression of the IL-6 family cytokines in human brain tumors
Lilja, A., Nordborg, C., Brun, A. E., Salford, L. G., & Åman, P. (2001) · International Journal of Oncology · doi:10.3892/ijo.19.3.495 · Cited by 26
Long-term remission with allogenic bone marrow transplantation in systemic lupus erythematosus
Gur-Lavi, M. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199908)42:8 · Cited by 25
Interleukin-6 production by murine B cells and B cell lines
Hobbs, M. V., McEvilly, R. J., Koch, R. J., Cardenas, G. J., & Noonan, D. J. (1991) · Cellular Immunology · doi:10.1016/0008-8749(91)90041-9 · Cited by 23
Interleukin-6 Trans-Signaling Regulates Glycogen Consumption After d -Galactosamine-Induced Liver Damage
Drucker, C., Rabe, B., Chalaris, A., Schulz, E., Scheller, J., & Rose‐John, S. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0095 · Cited by 15
IL-6-trans-signalling increases rapid-eye-movement sleep in rats
May, U., Schiffelholz, T., Baier, P. C., Krueger, J. M., Rose‐John, S., & Scheller, J. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.04.023 · Cited by 14
The systematic search for risk factors in multiple sclerosis
McKay, K. A., & Tremlett, H. L. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70015-3 · Cited by 7
The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2
Eugster (1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1521-4141(199807)28:07 · Cited by 2
Untitled work
(1999) · doi:10.1002/(sici)1098-1136(19990215)25:4

Research works printed but not linked: 1

Marz, 1999, Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression, Glia, 26, 191, 10.1002/(SICI)1098-1136(199905)26:3<191::AID-GLIA1>3.0.CO;2-# · DOI

Sorted by citations

Inflammation as a central mechanism in Alzheimer's disease
Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., & Lamb, B. T. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.06.014 · Cited by 2,253
“[210] Rothaug M, Becker-Pauly C, Rose-John S.”
Background
Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update
Su, H., Lei, C., & Zhang, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00405 · Cited by 554
Repopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner
Willis, E. F., MacDonald, K. P. A., Nguyen, Q. H., Garrido, A. L., Gillespie, E. R., Harley, S. B. R., Bartlett, P. F., Schroder, W. A., Yates, A. G., Anthony, D. C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.013 · Cited by 520
Post-stroke inflammation—target or tool for therapy?
Lambertsen, K. L., Finsen, B. R., & Clausen, B. H. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1930-z · Cited by 477
What does plasma CRP tell us about peripheral and central inflammation in depression?
Felger, J. C., Haroon, E., Patel, T. A., Goldsmith, D. R., Wommack, E. C., Woolwine, B. J., Le, N.-A., Feinberg, R., Tansey, M. G., & Miller, A. H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0096-3 · Cited by 448

See all 498

Authors: Rothaug, M., Becker-Pauly, C., & Rose-John, S.
Affiliations: Christian-Albrechts-Universität zu Kiel (DE)
Venue: Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Publisher: Elsevier BV
Published: 2016-06
Volume: 1863
Issue: 6
Pages: 1218-1227
ISSN: 0167-4889 (ISSN-L)
DOI: 10.1016/j.bbamcr.2016.03.018
OpenAlex: W2308447553
Cited by: 491
References: 170
Citations by year: 2026: 30 · 2025: 51 · 2024: 44 · 2023: 54 · 2022: 89 · 2021: 74 · 2020: 59 · 2019: 37 · 2018: 22 · 2017: 23 · 2016: 8
FWCI: 3.02
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 365 d)
Locations: Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (publishedVersion)
PubMed (publishedVersion)
Funders: Deutsche Forschungsgemeinschaft (SFB 654)
Proteolysis as a Regulatory Event in Pathophysiology (SFB 877)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords: interleukin-6, IL-6 signaling, neuroinflammation, multiple sclerosis, Parkinson's disease, Alzheimer's disease, sleep, REM sleep, oligodendrocyte differentiation, peripheral nerve regeneration, neurotrophic factors, soluble IL-6 receptor, gp130, trans-signaling, sgp130Fc, neurodegeneration, microglia
MeSH terms: Animals, Central Nervous System, Humans, Models, Biological, Protein Binding, Signal Transduction, Interleukin-6, Neurodegenerative Diseases, Receptors, Interleukin-6, Cytokine Receptor gp130

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The role of interleukin-6 signaling in nervous tissue

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks